Endothelial dysfunction and elevation of S-adenosylhomocysteine in cystathionine β-synthase-deficient mice

Circulation Research

Volumn 88, Issue 11, 2001, Pages 1203-1209

  Dayal, Sanjana ^a   Bottiglieri, Teodoro ^c   Arning, Erland ^c   Maeda, Nobuyo ^d   Malinow, M René ^e   Sigmund, Curt D ^a   Heistad, Donald D ^a,b   Faraci, Frank M ^a   Lentz, Steven R ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Acetylcholine; Endothelium; Homocysteine; Methylation; Thrombomodulin

Indexed keywords

CYSTATHIONINE BETA SYNTHASE; S ADENOSYLHOMOCYSTEINE;

AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ARTICLE; CARDIOVASCULAR DISEASE; HOMOCYSTINURIA; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; TISSUE LEVEL; VASCULAR ENDOTHELIUM;

EID: 0035827728     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/hh1101.092180     Document Type: Article

References (43)

1. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of increasing folic acid intakes
2. Homocyst(e)ine and cardiovascular disease: A critical review of the epidemiologic evidence
3. Homocysteine and cardiovascular disease
4. Homocysteine and arteriosclerosis: Subclinical and clinical disease associations
5. Blood levels of homocysteine and increased risks of cardiovascular disease: Causal or casual?
6. Hyperhomocysteinemia and oxidative stress: Time for a reality check?
7. Folic acid reverts dysfunction of endothelial nitric oxide synthase
8. Folate dependence of hyperhomocysteinemia and endothelial dysfunction in cystathionine β-synthase-deficient mice
9. Homocysteine and hypomethylation: A novel link to vascular disease
10. Disorders of transsulfuration
11. ras methylation in vascular endothelial cells by homocysteine but not cysteine
12. Mice deficient in cystathionine β-synthase: Animal models for mild and severe homocyst(e)inemia
13. Responses of carotid artery in mice deficient in expression of the gene for endothelial NO synthase
14. Gene transfer of endothelial nitric oxide synthase (eNOS) in eNOS-deficient mice
15. Atherosclerosis, vascular remodeling, and impairment of endothelium-dependent relaxation in genetically altered hyperlipidemic mice
16. Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia
17. Homocysteine and its disulfide derivatives: A suggested consensus terminology
18. Prevalence of hyperhomocyt(e)inemia in patients with peripheral arterial occlusive disease
19. Homocyst(e)inemia in daily practice: Levels in coronary artery disease
20. Plasma total homocysteine measurement by ion-paired reversed-phase HPLC with electrochemical detection
21. Isocratic high performance liquid chromatography analysis of S-adenosylmethionine and S-adenosylhomocysteine in animal tissues: The effect of exposure to nitrous oxide
22. Effects of homocysteine on acetylcholine- and adenosine-induced vasodilatation of pancreatic vascular bed in rats
23. Superoxide-dependent cerebrovascular effects of homocysteine
24. Dysfunction of nitric oxide mediation in isolated rat arterioles with methionine diet-induced hyperhomocysteinemia
25. Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia
26. The oxidant stress of hyperhomocyst(e)inemia
27. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine
28. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia
29. Elevation of asymmetric dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst(e)inemia in humans
30. The asymmetrical dimethylarginine/dimethylarginine dimethylaminohydrolase pathway in the regulation of nitric oxide production
31. Novel mechanism for endothelial dysfunction: Dysregulation of dimethylarginine dimethylaminohydrolase
32. Mice deficient in methylene tetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition
33. Folate-deficiency-induced homocysteinaemia in rats: Disruption of S-adenosylmethionine's co-ordinate regulation of homocysteine metabolism
34. Mechanism of erythrocyte accumulation of methylation inhibitor S-adenosylhomocysteine in uremia
35. Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation
36. Depression of catalase gene expression after immortalization and transformation of mouse liver cells
37. Plasma S-adenosylhomocysteine is a more sensitive indicator of cardiovascular disease than plasma homocysteine
38. Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells
39. Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine
40. An atherogenic stimulus homocysteine inhibits cofactor activity of thrombomodulin and enhances thrombomodulin expression in human umbilical vein endothelial cells
41. Hyperhomocysteinemia, atherosclerosis and thrombosis
42. Oxidation of a specific methionine in thrombomodulin by activated neutrophil products blocks cofactor activity: A potential rapid mechanism for modulation of coagulation
43. Human protein C receptor is present primarily on endothelium of large blood vessels: Implications for the control of the protein C pathway